VALIANT-STEMI
Research type
Research Study
Full title
Virtual ward-Assisted very earLy dIschArge of low-rIsk STEMI patieNTs: the VALIANT-STEMI trial
IRAS ID
337716
Contact name
Muzahir H Tayebjee
Contact email
Clinicaltrials.gov Identifier
Clinicaltrials.gov Identifier
N/A, N/A
Duration of Study in the UK
1 years, 11 months, 31 days
Research summary
Observational studies have suggested that early discharge (24hrs with follow up virtually by telephone) of patients who are low risk and have had successful treatment following ST elevation myocardial infarction is safe. This has not been tested in a randomised controlled trial. In this trial we propose to identify low risk patients and randomise them to usual care or early discharge and follow up virtually by telephone. The primary endpoint would be readmission to hospital or all cause death up to 30 day following the event. If the outcome is positive, the study will assist early discharge of patients, reduce length of stay, potentially improve patient well being and have positive financial implications for the health service.
REC name
West Midlands - Solihull Research Ethics Committee
REC reference
24/WM/0049
Date of REC Opinion
28 May 2024
REC opinion
Further Information Favourable Opinion